BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16397384)

  • 21. Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone.
    Behre HM; Kliesch S; Lemcke B; von Eckardstein S; Nieschlag E
    Hum Reprod; 2001 Dec; 16(12):2570-7. PubMed ID: 11726576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
    Christiansen P; Skakkebaek NE
    Horm Res; 2002; 57(1-2):32-6. PubMed ID: 12006717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of fertility problems in the male dog.
    Larsen RE
    Vet Clin North Am; 1977 Nov; 7(4):735-45. PubMed ID: 337632
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of testosterone response to intramuscular injection of GnRH and its correlation with sperm quality parameters in cockerels.
    Barna J; Mézes M
    Acta Vet Hung; 1994; 42(4):481-5. PubMed ID: 7810447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone.
    Purswell BJ; Wilcke JR
    J Reprod Fertil Suppl; 1993; 47():335-41. PubMed ID: 8229946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Surgical and Immunological Castration on Haematological Variables, Reproductive Hormones and Ejaculate Characteristics in Mongrel Dogs.
    Ajadi TA; Gazal OS
    Niger J Physiol Sci; 2016 Aug; 31(1):37-42. PubMed ID: 27574762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Documented and anecdotal effects of certain pharmaceutical agents used to enhance semen quality in the dog.
    Hess M
    Theriogenology; 2006 Aug; 66(3):613-7. PubMed ID: 16716383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of semen quality following reversible downregulation of testicular function in male dogs with a GnRH agonist implant.
    Goericke-Pesch S; Ludwig C; Hoffmann B
    Reprod Domest Anim; 2012 Aug; 47(4):625-8. PubMed ID: 22050326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive.
    Linde R; Doelle GC; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    N Engl J Med; 1981 Sep; 305(12):663-7. PubMed ID: 6267464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
    Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
    J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intranasal gonadotropin-releasing hormone (GnRH) therapy for men with idiopathic infertility: GnRH stimulation test may predict response to treatment.
    Chow VD; Jarvi KA; Buckspan M; Barry-Longley T; Zini A
    Fertil Steril; 2000 Sep; 74(3):605-6. PubMed ID: 10973666
    [No Abstract]   [Full Text] [Related]  

  • 33. Free sex steroid and sex hormone-binding globulin levels in oligozoospermic men with varicoceles.
    Hudson RW
    Fertil Steril; 1996 Aug; 66(2):299-304. PubMed ID: 8690120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in semen quality and Leydig cell function in infertile men: a longitudinal study.
    Olesen IA; Joensen UN; Petersen JH; Almstrup K; Rajpert-De Meyts E; Carlsen E; McLachlan R; Juul A; Jørgensen N
    Hum Reprod; 2018 Nov; 33(11):1963-1974. PubMed ID: 30247578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido.
    Pavlou SN; Brewer K; Farley MG; Lindner J; Bastias MC; Rogers BJ; Swift LL; Rivier JE; Vale WW; Conn PM
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1360-9. PubMed ID: 1955518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
    Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
    Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of HCG or gonadoreline on seminal parameters and plasma testosterone levels in young male rabbits.
    Rebollar PG; Ubilla E; Alvariño JM; Lorenzo PL; Silván G; Illera JC
    J Physiol Biochem; 1998 Sep; 54(3):161-6. PubMed ID: 10217213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor semen quality in Irish wolfhounds: a clinical, hormonal and spermatological study.
    Dahlbom M; Andersson M; Huszenicza G; Alanko M
    J Small Anim Pract; 1995 Dec; 36(12):547-52. PubMed ID: 8926724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
    Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
    J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between serum hormone levels and semen quality among men from an infertility clinic.
    Meeker JD; Godfrey-Bailey L; Hauser R
    J Androl; 2007; 28(3):397-406. PubMed ID: 17135633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.